-
Alefacept is a
genetically engineered immunosuppressive drug. It was sold
under the
brand name
Amevive in Canada, the
United States, Israel, Switzerland...
- cyclophosphamide, mycophenolate,
intravenous immunoglobulin, rituximab, sirolimus,
alefacept, and the
tyrosine kinase inhibitors, imatinib, nilotinib, and dasatinib...
-
Antithymocyte immunoglobulin (rabbit) L04AA06
Mycophenolic acid L04AA15
Alefacept L04AA19
Gusperimus L04AA22
Abetimus L04AA24
Abatacept L04AA28 Belatacept...
- thalidomide, etretinate,
cyclosporine and, most recently,
intramuscular alefacept may
control the
disease but are
ineffective for
severe chronic or relapsing...
-
ulcerative colitis, Crohn's
disease monoclonal antibody TNF
antagonist alefacept Amevive chronic plaque psoriasis immunoglobin G1
fusion protein incompletely...
-
adverse effects. Two
medications that
target T
cells are
efalizumab and
alefacept.
Efalizumab is a
monoclonal antibody that
specifically targets the CD11a...
- (amphotericin B) – Anti-fungal –
marketed with
Gilead Sciences.
Amevive (
alefacept) –
plaque psoriasis Astagraf XL (tacrolimus) –
Prevention of post-transplant...
-
Antibodies -cept (Fusion) CTLA-4
Abatacept Belatacept TNF
inhibitor Etanercept Opinercept Aflibercept Alefacept Rilonacept...
- IL-1
receptors to
treat cryopyrin-****ociated
periodic syndromes (CAPS).
Alefacept:
Regulated T-cell
responses by
selectively targeting effector memory T-cells...
- (INN)
Aldoclor Aldomet Aldoril aldosterone (INN)
Aldurazyme Alecensa alefacept (USAN)
aleglitazar (USAN, INN)
alemtuzumab (INN)
alendronic acid (INN)...
